Demand for peptide synthesis has increased significantly in the past decade and the approval of peptide-based diagnosis therapy solution has witnesse ...
I reiterate a “Buy” rating on Agilent Technologies, Inc. with a one-year target price of $150 per share, driven by strategic ...
MORRISVILLE, N.C., November 12, 2024--(BUSINESS WIRE)--To facilitate large-scale production of peptide drugs ... and the structural design of the synthesizer required careful attention.
2d
The global cancer peptide therapeutics market is experiencing significant growth as peptides gain recognition as effective, targeted therapies for cancer treatment. Peptides, which are short chains of ...
The expansion in Building 2 will feature state-of-the-art fragment-based peptide synthesis capabilities with multiple 1000L to 3000L solid-phase and liquid-phase peptide synthesis equipment lines.
To facilitate large-scale production of peptide drugs, Asymchem (stock codes: 002821.SZ/6821.HK), a leading global pharmaceutical contract development and manufacturing organization (CDMO), has ...
MORRISVILLE, N.C., November 12, 2024--(BUSINESS WIRE)--To facilitate large-scale production of peptide drugs, Asymchem (stock codes ... of resin with reactants and the structural design of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback